Pathstone Family Office’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-57
Closed -$5K 581
2018
Q3
$5K Buy
57
+11
+24% +$938 ﹤0.01% 185
2018
Q2
$4K Hold
46
﹤0.01% 142
2018
Q1
$3K Hold
46
﹤0.01% 312
2017
Q4
$3K Buy
+46
New +$2.94K ﹤0.01% 128
2017
Q2
Sell
-350
Closed -$23K 703
2017
Q1
$23K Buy
+350
New +$24.1K 0.01% 233
2016
Q4
Sell
-12,373
Closed -$873K 229
2016
Q3
$873K Buy
12,373
+5,250
+74% +$393K 0.9% 12
2016
Q2
$540K Buy
7,123
+6,773
+1,935% +$498K 0.51% 14
2016
Q1
$24K Hold
350
0.05% 71
2015
Q4
$31K Sell
350
-888
-72% -$76.1K 0.14% 27
2015
Q3
$100K Hold
1,238
0.27% 24
2015
Q2
$110K Hold
1,238
0.18% 20
2015
Q1
$107K Hold
1,238
0.17% 25
2014
Q4
$105K Hold
1,238
0.36% 17
2014
Q3
$88K Hold
1,238
0.27% 23
2014
Q2
$86K Buy
1,238
+888
+254% +$62.5K 0.24% 21
2014
Q1
$26K Hold
350
0.07% 48
2013
Q4
$25K Sell
350
-125
-26% -$8.16K 0.05% 89
2013
Q3
$30K Hold
475
0.13% 107
2013
Q2
$30K Buy
+475
New +$28.6K 0.03% 163

Other funds holding ESRX

Pathstone Family Office's ESRX Position: Q4 2018 in Review

Pathstone Family Office sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 57 shares — an estimated $5K sold.

Pathstone Family Office first reported a position in ESRX in Q2 2013 and held it in 19 quarters. The position peaked at $873K in Q3 2016. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Pathstone Family Office reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Pathstone Family Office sold 57 Express Scripts Holding Company shares in Q4 2018, an estimated $5K.
  • Pathstone Family Office first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 19 quarters.
  • Pathstone Family Office's Express Scripts Holding Company position peaked at $873K in Q3 2016.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Pathstone Family Office's 13F filing for Q4 2018, filed 14 Feb 2019.